10-Q | 2020-10-31 | Filed 2020-12-21 |
S-1 | 2020-08-20 | Public Filing |
10-K | 2020-07-31 | Filed 2020-11-13 |
S-1 | 2020-06-15 | Public Filing |
10-Q | 2020-04-30 | Filed 2020-06-22 |
S-1 | 2020-02-18 | Public Filing |
10-Q | 2020-01-31 | Filed 2020-03-20 |
S-1 | 2019-12-12 | Public Filing |
10-Q | 2019-10-31 | Filed 2019-12-16 |
10-K | 2019-07-31 | Filed 2019-11-12 |
10-Q | 2019-04-30 | Filed 2019-06-19 |
10-Q | 2019-01-31 | Filed 2019-03-25 |
8-K | 2021-02-19 | Other Events |
8-K | 2021-02-17 | Enter Agreement, Off-BS Arrangement, Sale of Shares |
8-K | 2021-02-08 | Other Events |
8-K | 2021-02-01 | Other Events, Exhibits |
8-K | 2021-01-06 | Enter Agreement, Exhibits |
8-K | 2020-12-15 | Enter Agreement, Exhibits |
8-K | 2020-11-23 | |
8-K | 2020-11-19 | |
8-K | 2020-11-18 | |
8-K | 2020-11-05 | |
8-K | 2020-10-05 | |
8-K | 2020-09-24 | |
8-K | 2020-09-18 | |
8-K | 2020-08-25 | |
8-K | 2020-08-04 | |
8-K | 2020-07-31 | |
8-K | 2020-07-13 | |
8-K | 2020-06-24 | |
8-K | 2020-06-23 | |
8-K | 2020-06-22 | |
8-K | 2020-06-19 | |
8-K | 2020-06-18 | |
8-K | 2020-06-17 | |
8-K | 2020-06-16 | |
8-K | 2020-06-15 | |
8-K | 2020-06-11 | |
8-K | 2020-06-10 | |
8-K | 2020-06-09 | |
8-K | 2020-06-08 | |
8-K | 2020-06-02 | |
8-K | 2020-05-14 | |
8-K | 2020-03-12 | |
8-K | 2020-03-03 | |
8-K | 2020-02-28 | |
8-K | 2020-01-27 | |
8-K | 2019-11-22 | |
8-K | 2019-11-19 | |
8-K | 2019-10-29 | |
8-K | 2019-10-28 | |
8-K | 2019-10-25 | |
8-K | 2019-07-11 | |
8-K | 2019-05-06 | |
8-K | 2019-04-01 | |
8-K | 2019-03-29 | |
8-K | 2019-03-25 | |
8-K | 2019-02-21 | |
8-K | 2019-02-15 | |
8-K | 2019-02-13 | |
8-K | 2019-02-08 | |
8-K | 2019-01-25 | |
8-K | 2019-01-24 | |
8-K | 2019-01-15 | |
8-K | 2019-01-07 | |
8-K | 2019-01-07 |
Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546,418 | 322,654 | 0 | 0 | 0 | 0 | -853,740 | |||
1 800 Flowers Com (FLWS) | 944,324 | 42% | 13.3 | 6% | 664,955 | 335,559 | 1,266,390 | 533,727 | 36,761 | 75,090 | 1,000,932 |
10x Genomics (TXG) | 4,804,979 | 75% | -490.3 | -2% | 572,815 | 151,367 | 61,207 | 45,727 | -9,603 | -8,887 | 4,357,180 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1,118 | 20,421 | 625 | 199 | -15,491 | -14,800 | 966 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 33,711 | 0% | 0.4 | -5% | 164,088 | 108,405 | 18,194 | 0 | -7,969 | -8,017 | -2,855 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 18,527 | 23,194 | 27,219 | 6,699 | -2,862 | -1,433 | 3,396 | |
1895 Bancorp of Wisconsin (BCOW) | 46,152,715 | 12,508.1 | -0% | 441,187 | 382,722 | 0 | 0 | -44 | 3,689 | 46,142,359 | |
1st Constitution Bancorp (FCCY) | 164,504 | 0% | 4.4 | 1% | 1,342,565 | 1,204,038 | 490 | 0 | 13,787 | 32,503 | 143,748 |
1st Franklin Financial (FFC) | 3,551 | -0.6 | 7% | 905,107 | 644,730 | 0 | 0 | 62,078 | 80,004 | -45,962 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200,033 | 7.9 | 1% | 6,691,070 | 5,858,028 | 0 | 0 | 70,061 | 136,342 | 1,072,548 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 1,849 | 0 | 0 | -1,663 | -1,654 | 250 | |
21Vianet Group (VNET) | 6,005,116 | 0% | 11,150,717 | 5,787,533 | 0 | 0 | 0 | 0 | 3,344,095 | ||
22nd Century (XXII) | 301,854 | 1% | -14.1 | -36% | 61,864 | 6,554 | 25,706 | 304 | -22,433 | -21,464 | 301,826 |
1Life Healthcare (ONEM) |
Balance Sheet ($'000) | 2019-04-30 | 2019-07-31 | 2019-10-31 |
Cash | 1,408 | 298 | 540 |
Accounts Receivable | 1,803 | 36 | 155 |
Inventory | 250 | 363 | 727 |
PP&E | 666 | 640 | 769 |
Assets | 54,036 | 49,636 | 52,240 |
Accounts Payable | |||
Long-Term Debt | 530 | 447 | |
Liabilities | 40,233 | 37,889 | 43,297 |
Stockholders' Equity | 13,803 | 7,673 | 4,869 |
Income Statement ($'000) | 2019-04-30 | 2019-07-31 | 2019-10-31 |
Revenue | 1,093 | -51 | 722 |
Cost of Revenue | 1,265 | -9 | 134 |
Gross Profit | -172 | -42 | 588 |
R&D | 472 | 286 | 339 |
SG&A | 8,657 | 3,864 | 4,787 |
Tax | |||
Net Income | -11,153 | -5,251 | -9,313 |
Cash Flow ($'000) | 2019-04-30 | 2019-07-31 | 2019-10-31 |
Cash Operating | -1,516 | -1,844 | |
Cash Investing | 36 | 45 | |
Cash Financing | 381 | 2,041 |